CVKD — Cadrenal Therapeutics, Inc.

CVKDCadrenal Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · cadrenal.com

4.751USD-4.41%Mkt Cap: 14.62M USDP/E: —Last update: 2026-06-01

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions. The company is developing Tecarfarin, an oral vitamin K …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap14.62M USD

Enterprise Value11.77M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-13.24M USD

Revenue/Share—

Last Price4.751 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees5

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.27

PEG—

EV/EBITDA-0.98

EV/Revenue—

P/S—

P/B6.92

EPS (TTM)-5.59

EPS (Forward)-3.91

52W Range

4.2105% of range15.99

52W High15.99 USD

52W Low4.210 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-483.34%

ROA-305.95%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-12.60M USD

CapEx (TTM)5.10K USD

FCF Margin—

FCF Yield-43.10%

Net Debt-2.31M USD

Net Debt/EBITDA0.19

Balance Sheet

Debt/Equity—

Current Ratio2.68

Quick Ratio2.17

Book Value/Sh0.7170 USD

Cash/Share0.8050 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:15

Split DateAug 20, 2024

Analyst Consensus

Rating—

Target (Mean)27.67 USD

Target Range13.00 USD – 45.00 USD

# Analysts3

Ownership

Shares Out.3.08M

Float2.38M

Insiders18.20%

Institutions5.97%

Short Interest

Short Ratio1.0d

Short % Float2.71%

Short % Out.2.30%

Shares Short70.93K

Short (prev mo.)43.51K

Technical

SMA 505.412 (-12.2%)

SMA 2009.112 (-47.9%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)61.11K

Avg Vol (10d)57.32K

Technical Indicators

RSI (14)42.7

MACD-0.1882

MACD Signal-0.1482

MACD Hist.-0.0400

BB Upper6.604 USD

BB Middle5.470 USD

BB Lower4.337 USD

BB Width41.44%

ATR (14)0.5638 USD

Vol Ratio (20d)0.36x